Counterpoint Global
VC Fund
New York, United States
Counterpoint Global is a VC fund in New York focused on Software and Biotechnology. Counterpoint Global is one of Morgan Stanley's fundamental equity teams that aims to make long-term investments in unique companies. The culture of the team promotes collaboration, creativity, ongoing development, and differentiated thinking. Company portfolios are normally concentrated and differentiated from their benchmarks. CounterpointGlobal is made up of 35 individuals, including 18 investment professionals and two disruptive change researchers.
- Total investments:
- 21
- Last investment:
- Lead investor:
- 10%
Last updated:
For AI agents: llms.txt
Industries Counterpoint Global invests in
SoftwareBiotechnologyHealth DiagnosticsHealth CareMachine Learning
Stages Counterpoint Global invests in
Post-IPO EquitySeries DSeries CSeries ESeries F
Countries Counterpoint Global invests in
United StatesIsraelSingaporeUnited Kingdom
Investment Focus
Industry
- Software 6 (29%)
- Biotechnology 5 (24%)
- Health Diagnostics 4 (19%)
- Health Care 3 (14%)
- Machine Learning 3 (14%)
Stage
- Post-IPO Equity 9 (43%)
- Series D 4 (19%)
- Series C 3 (14%)
- Series E 2 (10%)
- Series F 2 (10%)
Country
- United States 17 (81%)
- Israel 1 (5%)
- Singapore 1 (5%)
- United Kingdom 1 (5%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
PsiQuantum
|
PsiQuantum develops quantum computing technologies using photonic qubits and silicon photonics to build fault-tolerant quantum computing systems. The company designs quantum hardware, software, and system architectures that support the development and operation of scalable quantum computers. It manufactures quantum photonic chips throughsemiconductor fabrication processes and develops cryogenic infrastructure and quantum algorithms for large-scale computing applications. PsiQuantum also collaborates with research institutions, government organizations, and industry partners on quantum computing research and technology development. Its work focuses on advancing quantum computing capabilities for scientific, industrial, and computational applications. | $1B / Series E / Sep 10, 2025 | |
Infleqtion
|
Infleqtion, with offices in the United States, United Kingdom, and Australia, delivers high-value quantum information precisely where it is needed. By operating at the Edge, our software-configured, quantum-enabled products deliver unmatched levels of precision and power, generating streams of high-value information for commercial organizations,the United States, and allied governments. With 17 years of ColdQuanta's pioneering quantum research as our foundation, our hardware products and AI-powered solutions address critical market needs in positioning, navigating, and timing, global communication security and efficiency, resilient energy distribution, and accelerated quantum computing. Learn how Infleqtion is revolutionizing how we communicate, navigate, and discover at www.Infleqtion.com and connect with us on LinkedIn. | $100M / Series C / Jun 02, 2025 | |
Clear Labs
|
Clear Labs harnesses the power of next-generation sequencing (NGS) to simplify complex diagnostics for clinical and applied markets. By creating a fully automated platform that brings together DNA sequencing, robotics, and cloud-based analytics, Clear Labs democratizes genomics applications to deliver increased clarity.Clear Labs’ turnkeyplatform accelerates outcomes and improves accuracy - from food-borne pathogens to infectious diseases, including SARS CoV-2. With a novel approach, Clear Labs is helping the world better understand, track, and mitigate tomorrow’s novel pathogens. | $30M / Series D / Jan 13, 2025 | |
Anduril Industries
|
Anduril Industries is a defense product company that builds technology for military agencies and border surveillance. Anduril commits top technical talent to solving the most complex national security challenges. We’re building the next generation of technology that will aid and protect those who serve on the front lines defending the nation andits interests.Our mission is to develop cutting edge technology that enables America and its allies to maintain global leadership now and into the future. | $1.5B / Series F / Aug 07, 2024 | |
ID.me
|
ID.me is a digital identity network that aims to simplify the user's indication verification experience. The company's platform streamlines authentication, identity proofing, and federation of external identity and attributes providers through a single API, enabling military, students, first responders, teachers, and government employeesto easily prove their identity online via a single login and avail discounts on various networks. | $132M / Series D / Apr 11, 2023 | |
Overtime
|
Overtime is a sports network for the next generation of sports fans. It produces original content across YouTube, Snapchat, and IGTV, as well as highly engaging short-form content on Instagram and TikTok.Based in NYC, Overtime is funded by top VC firms like Andreessen Horowitz and Greycroft Ventures as well as industry leaders like Kevin Durantand former NBA Commissioner David Stern. | $100M / Series D / Aug 09, 2022 | |
Heliogen
|
Heliogen is a renewable energy technology company focused on eliminating the need for fossil fuels in heavy industry and powering a sustainable future. The company’s AI-enabled, modular concentrated solar technology aims to cost-effectively deliver near 24/7 carbon-free energy in the form of heat, power, or green hydrogen fuel at scale – forthe first time in history. Heliogen was created at Idealab, the leading technology incubator founded by Bill Gross in 1996. For more information about Heliogen, please visit heliogen.com. | $165M / Post-IPO Equity / Dec 31, 2021 | |
Tipalti
|
Tipalti streamlines and automates the way companies make payments to their suppliers, partners, publishers, and crowd. Tipalti provides a comprehensive cloud-based solution that addresses all phases of the payables workflow, from self-service supplier onboarding and management to tax compliance, invoice processing, global funds disbursement, earlypayments, and AP reporting and payment reconciliation, while helping to ensure the payer in full tax and regulatory compliance.With Tipalti, companies can eliminate up to 80% of their supplier payment workload, helping them scale their business efficiently with global growth while strengthening financial and compliance controls and while improving the partner payment experience.Tipalti was founded on 2010 and is headquartered in San Mateo, California. | $270M / Series F / Dec 08, 2021 | |
Grab
|
Grab operates a mobile technology platform that integrates city transportation for driver-partners and customers in South East Asia. It offers services like GrabTaxi, GrabCar, GrabHitch, GrabShare, GrabCoach, GrabShuttle, GrabShuttle Plus, GrabFamily, JustGrab, GrabNow, and GrabRental. Grab offers services in Singapore, Indonesia, Philippines,Malaysia, Thailand, Vietnam, and Myanmar. Anthony Tan and Tan Hooi Lng founded it in 2012 and is headquartered in Singapore. It has additional offices in Seattle, Beijing, Bangalore, Jakarta, and Vietnam. | $4B / Post-IPO Equity / Dec 02, 2021 | |
Aurora
|
Aurora, founded in 2017 by the leading experts in self-driving, is delivering the benefits of self-driving technology safely, quickly, and broadly. To move both people and goods, the company is building the Aurora Driver, a platform that brings together software, hardware and data services to autonomously operate passenger vehicles, lightcommercial vehicles, and heavy-duty trucks. Aurora is backed by Amazon and Sequoia, among others, and partners with industry-leaders including Toyota, Uber, Volvo, and Paccar. Aurora tests its vehicles in the Bay Area, Pittsburgh, and Dallas. The company has offices in those areas as well as in Bozeman, MT; Seattle, WA; Louisville, CO; and Wixom, MI. To learn more, visit www.aurora.tech. | $1.8B / Post-IPO Equity / Nov 04, 2021 | |
| See all 21 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
SaaS Investors
99,274 investors
Software Investors
50,021 investors
Health Care Investors
43,014 investors
Artificial intelligence Investors
40,702 investors
Biotech Investors
21,775 investors
Biotechnology Investors
19,370 investors
Machine Learning Investors
17,935 investors
SaaS VC Funds
61,208 investors
Software VC Funds
31,919 investors
FAQ
What does Counterpoint Global invest in?
Counterpoint Global invests primarily in Software, Biotechnology and Health Diagnostics startups, most often at Post-IPO Equity and Series D stage. Most of the 21 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Counterpoint Global last invest?
The most recent investment recorded for Counterpoint Global closed in Sep 2025. Shizune tracks 21 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
